Does low angiopoietin-1 predict adverse outcome in sepsis?

Critical Care

Volumn 14, Issue 4, 2010, Pages

  David, Sascha ^a   van Meurs, Matijs ^a,b   Kümpers, Philipp ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN; ANGPT1 PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADVERSE OUTCOME; ANGIOGENESIS; BACTERIAL INFECTION; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CHILD; DISEASE SEVERITY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; INTENSIVE CARE; MALAWI; MORTALITY; NOTE; OUTCOME ASSESSMENT; PATHOGENESIS; PERICYTE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SMOOTH MUSCLE FIBER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; BLOOD; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANGIOPOIETIN-1; BIOLOGICAL MARKERS; CHILD; HUMANS; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 79952117731     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9090     Document Type: Note

References (14)

1. Mankhambo LA, Banda DL, Jeffers G, White SA, Balmer P, Nkhoma S, Phiri H, Molyneux EM, Hart CA, Molyneux ME, Heyderman RS, Carrol ED. The IPD Study Group The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care 2010, 14:R91. 10.1186/cc9025, 20492647, The IPD Study Group.
2. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG. Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation. Nat Med 2006, 12:235-239. 10.1038/nm1351, 16462802.
3. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005, 111:97-105. 10.1161/01.CIR.0000151287.08202.8E, 15611372.
4. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3:e46. 1334221, 16417407, 10.1371/journal.pmed.0030046.
5. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12:R147. 2646310, 19025590, 10.1186/cc7130.
6. Kumpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2010, 36:462-470. 10.1007/s00134-009-1726-7, 19956923.
7. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009, 31:348-353. 10.1097/SHK.0b013e318188bd06, 18791490.
8. van der Heijden M, Pickkers P, Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB. Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009, 35:1567-1574. 2726915, 19551369, 10.1007/s00134-009-1560-y.
9. Kumpers P, van Meurs M, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009, 13:R64. 2717419, 19416526, 10.1186/cc7866.
10. Giuliano JS, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS. Admission angiopoietin levels in children with septic shock. Shock 2007, 28:650-654. 2754128, 18092380.
11. Giuliano JS, Lahni PM, Bigham MT, Manning PB, Nelson DP, Wong HR, Wheeler DS. Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass. Intensive Care Med 2008, 34:1851-1857. 2574898, 18516587, 10.1007/s00134-008-1174-9.
12. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, Krudsood S, Looareesuwan S, John CC, Liles WC, Kain KC. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 2009, 4:e4912. 2657207, 19300530, 10.1371/journal.pone.0004912.
13. van Meurs M, Kumpers P, Ligtenberg JJ, Meertens JH, Molema G, Zijlstra JG. Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?. Crit Care 2009, 13:207. 2689450, 19435476, 10.1186/cc7153.
14. Lukasz A, Hellpap J, Horn R, Kielstein JT, David S, Haller H, Kumpers P. Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Crit Care 2008, 12:R94. 2575578, 18664247, 10.1186/cc6966.